Abstract
GEN EdgeVol. 4, No. 1 Cell TherapyHow's the Biotechnology Business? A Conversation with Chris Garabedian, Brad Loncar, and Daphne ZoharPublished Online:18 Oct 2022https://doi.org/10.1089/genedge.4.1.127AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"How's the Biotechnology Business? A Conversation with Chris Garabedian, Brad Loncar, and Daphne Zohar." GEN Edge, 4(1), pp. 770–771FiguresReferencesRelatedDetails Volume 4Issue 1Jan 2022 Information© 2022 by GEN PublishingTo cite this article:How's the Biotechnology Business? A Conversation with Chris Garabedian, Brad Loncar, and Daphne Zohar.GEN Edge.Jan 2022.770-771.http://doi.org/10.1089/genedge.4.1.127Published in Volume: 4 Issue 1: October 18, 2022PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
